XML 91 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Total revenue $ 391,695 $ 1,502,748
Operating expenses:    
Research and development 28,587,884 24,618,399
General and administrative 31,085,274 32,432,510
Total operating expenses 59,673,158 57,050,909
Loss from operations (59,281,464) (55,548,161)
Other income (expense), net 6,942,505 1,379,132
Loss before provision for income taxes (52,338,959) (54,169,029)
Provision for income taxes 0 0
Net loss $ (52,338,959) $ (54,169,029)
Net loss per share, basic (in USD per share) $ (0.74) $ (0.77)
Net loss per share, diluted (in USD per share) $ (0.74) $ (0.77)
Weighted-average common shares outstanding, basic (in shares) 70,580,604 70,424,819
Weighted-average common shares outstanding, diluted (in shares) 70,580,604 70,424,819